Showing results 2 to 6 of 6
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
IMC-I109V, a novel T cell receptor (TCR) bispecific (ENVxCD3) designed to eliminate HBV-infected hepatocytes in chronic HBV patients: initial data from a first-in-human study. Poster Presentation (SAT437) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology | 2022 | ||
Preliminary results from a phase 2 study evaluating VIR-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International | 2022 | ||
Preliminary results from a phase 2 study evaluating vir-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:Oral Presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | ||
2019 | |||
2021 |